Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Bottom Line GLP-1 agonists have a place in medicine as treatment for Type 2 diabetes and obesity, offering benefits in blood sugar control and weight loss
Drugs such as Ozempic, Wegovy, Mounjaro and Zepbound are synthetic versions of GLP-1s that were created decades ago to treat diabetes but more recently have proven effective in weight loss
24 JAMA Internal Medicine report says that popular GLP-1s need to be rebranded from weight loss drugs to weight management drugs since some people may need to take them indefinitely
The medication itself causes appetite suppression that makes eating these nutrient-dense foods less appealing
